✦ LIBER ✦

Adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic adenocarcinoma

✍ Scribed by Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Naoya Nakagawa; Hiroki Ohge; Taijiro Sueda

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1671 Prognostic Impact of Dihydropyrimi

✍ Kondo, Naru; Murakami, Yoshiaki; Uemura, Kenichiro; Hayashidani, Yasuo; Sudo, Ta 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Prognostic Impact of Dihydropyrimidine D

✍ Kondo, Naru ;Murakami, Yoshiaki ;Uemura, Kenichiro ;Sudo, Takeshi ;Hashimoto, Ya 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Long-term results of adjuvant gemcitabin

✍ Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Naka 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Impact of Adjuvant Gemcitabine Plus S-1

✍ Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Ha 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 172 KB

Prognostic Impact of Thymidylate Synthas

✍ Kobayashi, Hironori ;Murakami, Yoshiaki ;Uemura, Kenichiro ;Sudo, Takeshi ;Hashi 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 182 KB

S-1 vs. Gemcitabine as an Adjuvant Thera

✍ Okabayashi, Takehiro; Shima, Yasuo; Iwata, Jun; Morita, Sojiro; Sumiyoshi, Tatsu 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 715 KB